EP3496739
EFNASAMSETNINGAR SEM INNIHALDA AKTRÍLA-FJÖLPEPTÍÐ TIL AÐ NOTA Í MEÐFERÐ VIÐ LUNGNAHÁÞRÝSTINGI
Status:
EP einkaleyfi í gildi á ÍslandiEP appl. date:
14.7.2017EP published:
28.4.2021EP application number:
17828540.9
EP translation filed:
10.5.2021Grant published:
15.6.2021EPO information:
European Patent Register
Max expiry date:
13.7.2037Expiry date:
13.7.2026Next due date:
31.7.2026
Title:
COMPOSITIONS COMPRISING ACTRIIA POLYPEPTIDES FOR USE IN TREATING PULMONARY HYPERTENSION
Timeline
Today
14.7.2017EP application
28.4.2021EP Publication
10.5.2021Translation submitted
15.6.2021Registration published
13.7.2026Expires
Owner
Name:
Acceleron Pharma Inc.Address:
126 East Lincoln Avenue, Rahway, NJ 07065, US
Inventor
Name:
KUMAR, RavindraAddress:
Acton MA 01720, US
Name:
KNOPF, JohnAddress:
Carlisle MA 01741, US
Agent
Name:
Budde Schou A/SAddress:
Dronningens Tværgade 30, DK
Priority
Number:
201662362955 PDate:
15.7.2016Country:
US
Number:
201762453888 PDate:
2.2.2017Country:
US
Number:
201762510403 PDate:
24.5.2017Country:
US
Supplementary protection
SPC number:
SPC498
Classification
Categories:
A61K 38/17, A61K 47/68, A61P 7/00, A61P 11/00
Annual fees
Number
Paid
Expires
Payer
Number: 5
Paid: 21.7.2021
Expires: 13.7.2022
Payer: Patice ehf.
Number: 6
Paid: 15.6.2022
Expires: 13.7.2023
Payer: Árnason Faktor ehf.
Number: 7
Paid: 17.6.2023
Expires: 13.7.2024
Payer: Árnason Faktor ehf.
Number: 8
Paid: 13.6.2024
Expires: 13.7.2025
Payer: Árnason Faktor ehf.
Number: 9
Paid: 7.7.2025
Expires: 13.7.2026
Payer: Árnason Faktor ehf.